205 related articles for article (PubMed ID: 11006015)
21. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Hundemer M; Schmidt S; Condomines M; Lupu A; Hose D; Moos M; Cremer F; Kleist C; Terness P; Belle S; Ho AD; Goldschmidt H; Klein B; Christensen O
Exp Hematol; 2006 Apr; 34(4):486-96. PubMed ID: 16569595
[TBL] [Abstract][Full Text] [Related]
22. Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line.
Fleischhauer K; Tanzarella S; Wallny HJ; Bordignon C; Traversari C
J Immunol; 1996 Jul; 157(2):787-97. PubMed ID: 8752930
[TBL] [Abstract][Full Text] [Related]
23. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
Jäeger E; Bernhard H; Romero P; Ringhoffer M; Arand M; Karbach J; Ilsemann C; Hagedorn M; Knuth A
Int J Cancer; 1996 Apr; 66(2):162-9. PubMed ID: 8603805
[TBL] [Abstract][Full Text] [Related]
24. Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones.
Kirkin AF; thor Straten P; Hansen MR; Barfoed A; Dzhandzhugazyan KN; Zeuthen J
Cancer Immunol Immunother; 1999 Aug; 48(5):239-46. PubMed ID: 10478640
[TBL] [Abstract][Full Text] [Related]
25. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.
Schuurhuis DH; Lesterhuis WJ; Kramer M; Looman MG; van Hout-Kuijer M; Schreibelt G; Boullart AC; Aarntzen EH; Benitez-Ribas D; Figdor CG; Punt CJ; de Vries IJ; Adema GJ
Cancer Immunol Immunother; 2009 Jul; 58(7):1109-15. PubMed ID: 19018531
[TBL] [Abstract][Full Text] [Related]
26. Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.
Man S; Newberg MH; Crotzer VL; Luckey CJ; Williams NS; Chen Y; Huczko EL; Ridge JP; Engelhard VH
Int Immunol; 1995 Apr; 7(4):597-605. PubMed ID: 7547687
[TBL] [Abstract][Full Text] [Related]
27. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL).
Wölfel T; Hauer M; Klehmann E; Brichard V; Ackermann B; Knuth A; Boon T; Meyer Zum Büschenfelde KH
Int J Cancer; 1993 Sep; 55(2):237-44. PubMed ID: 7690346
[TBL] [Abstract][Full Text] [Related]
28. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
Kawakami Y; Eliyahu S; Sakaguchi K; Robbins PF; Rivoltini L; Yannelli JR; Appella E; Rosenberg SA
J Exp Med; 1994 Jul; 180(1):347-52. PubMed ID: 7516411
[TBL] [Abstract][Full Text] [Related]
29. The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17/gp100.
Zarour H; De Smet C; Lehmann F; Marchand M; Lethé B; Romero P; Boon T; Renauld JC
J Invest Dermatol; 1996 Jul; 107(1):63-7. PubMed ID: 8752841
[TBL] [Abstract][Full Text] [Related]
30. Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.
Nagorsen D; Servis C; Lévy N; Provenzano M; Dudley ME; Marincola FM; Lévy F
Cancer Immunol Immunother; 2004 Sep; 53(9):817-24. PubMed ID: 15133631
[TBL] [Abstract][Full Text] [Related]
31. pMel17 is recognised by monoclonal antibodies NKI-beteb, HMB-45 and HMB-50 and by anti-melanoma CTL.
Adema GJ; Bakker AB; de Boer AJ; Hohenstein P; Figdor CG
Br J Cancer; 1996 May; 73(9):1044-8. PubMed ID: 8624261
[TBL] [Abstract][Full Text] [Related]
32. Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Lesterhuis WJ; Schreibelt G; Scharenborg NM; Brouwer HM; Gerritsen MJ; Croockewit S; Coulie PG; Torensma R; Adema GJ; Figdor CG; de Vries IJ; Punt CJ
Cancer Immunol Immunother; 2011 Feb; 60(2):249-60. PubMed ID: 21069321
[TBL] [Abstract][Full Text] [Related]
33. Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
Sun JY; Senitzer D; Forman SJ; Chatterjee S; Wong KK
Cancer Immunol Immunother; 2003 Dec; 52(12):761-70. PubMed ID: 14564482
[TBL] [Abstract][Full Text] [Related]
34. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.
Shirai M; Okada H; Nishioka M; Akatsuka T; Wychowski C; Houghten R; Pendleton CD; Feinstone SM; Berzofsky JA
J Virol; 1994 May; 68(5):3334-42. PubMed ID: 7512163
[TBL] [Abstract][Full Text] [Related]
35. Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes.
Maziarz R; Allen H; Strominger JL; Flavell R; Biro PA; Burakoff SJ
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6276-80. PubMed ID: 3875858
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex.
Vitiello A; Marchesini D; Furze J; Sherman LA; Chesnut RW
J Exp Med; 1991 Apr; 173(4):1007-15. PubMed ID: 1706750
[TBL] [Abstract][Full Text] [Related]
37. Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition.
Voss CY; Deola S; Fleisher TA; Marincola FM
Immunol Res; 2009; 45(1):13-24. PubMed ID: 18696013
[TBL] [Abstract][Full Text] [Related]
38. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
Wentworth PA; Sette A; Celis E; Sidney J; Southwood S; Crimi C; Stitely S; Keogh E; Wong NC; Livingston B; Alazard D; Vitiello A; Grey HM; Chisari FV; Chesnut RW; Fikes J
Int Immunol; 1996 May; 8(5):651-9. PubMed ID: 8671652
[TBL] [Abstract][Full Text] [Related]
39. MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes.
Robila V; Ostankovitch M; Altrich-Vanlith ML; Theos AC; Drover S; Marks MS; Restifo N; Engelhard VH
J Immunol; 2008 Dec; 181(11):7843-52. PubMed ID: 19017974
[TBL] [Abstract][Full Text] [Related]
40. Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cells.
Susumu S; Nagata Y; Ito S; Matsuo M; Valmori D; Yui K; Udono H; Kanematsu T
Cancer Sci; 2008 Jan; 99(1):107-12. PubMed ID: 17991294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
